[Lisocabtagene maraleucel CAR-T cells - second line treatment in patients with relapsed or refractory large B cell lymphoma].
Autor: | Chanut M; Hôpital Saint-Louis, service d'hématologie-oncologie, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: mathilde.chanut@aphp.fr., Herbaux C; Hôpital Saint-Eloi, service d'hématologie clinique, 80, avenue Augustin-Fliche, 34090 Montpellier, France. |
---|---|
Jazyk: | francouzština |
Zdroj: | Bulletin du cancer [Bull Cancer] 2023 Oct; Vol. 110 (10), pp. 986-988. Date of Electronic Publication: 2023 Sep 01. |
DOI: | 10.1016/j.bulcan.2023.06.010 |
Databáze: | MEDLINE |
Externí odkaz: |